S Nakazawa
- Hematology top 2%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 5%
- Genetics top 5%
- Cellular and Molecular Neuroscience top 10%
- Co-authors
- Takuji IwasatoHidenobu MizunoKei AsayamaHidemasa HayashibeK SugitaKazushige DobashiKumiko GoiTakeshi Inukai
- Topics
- Chronic Myeloid Leukemia Treatments (10 papers)Acute Myeloid Leukemia Research (9 papers)Acute Lymphoblastic Leukemia research (9 papers)
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
S Nakazawa
50 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Hematology 451
- Molecular Biology 415
- Public Health, Environmental and Occupational Health 388
- Genetics 168
- Cellular and Molecular Neuroscience 166
Countries citing papers authored by S Nakazawa
This map shows the geographic impact of S Nakazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Nakazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Nakazawa more than expected).
Fields of papers citing papers by S Nakazawa
This network shows the impact of papers produced by S Nakazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Nakazawa. The network helps show where S Nakazawa may publish in the future.
Co-authorship network of co-authors of S Nakazawa
This figure shows the co-authorship network connecting the top 25 collaborators of S Nakazawa. A scholar is included among the top collaborators of S Nakazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Nakazawa. S Nakazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 25 | |
| 3 | 13 | |
| 4 | 8 | |
| 5 | 69 | |
| 6 | 30 | |
| 7 | 11 | |
| 8 | 1 | |
| 9 | 25 | |
| 10 | 58 | |
| 11 | 14 | |
| 12 | 10 | |
| 13 | 17 | |
| 14 | 46 | |
| 15 | 19 | |
| 16 | 22 | |
| 17 | 10 | |
| 18 | 54 | |
| 19 | 21 | |
| 20 | 120 |
About S Nakazawa
S Nakazawa is a scholar working on Hematology, Genetics and Cellular and Molecular Neuroscience, having authored 51 papers that have together received 1.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (10 papers), Acute Myeloid Leukemia Research (9 papers) and Acute Lymphoblastic Leukemia research (9 papers). The work is most often cited by research in Hematology (451 citations), Genetics (168 citations) and Public Health, Environmental and Occupational Health (388 citations). S Nakazawa has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Takuji Iwasato, Hidenobu Mizuno, Kei Asayama, Hidemasa Hayashibe, K Sugita, Kazushige Dobashi, Kumiko Goi, Takeshi Inukai, K Kagami and Seiji Kojima. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.